LINQ II Insertable Cardiac Monitor vs QFR
AI Verdict
Choose LINQ II Insertable Cardiac Monitor if…
Choose LINQ II if you require long-term, continuous monitoring of heart rhythms to diagnose infrequent or asymptomatic arrhythmias over an extended period. This tool is ideal for patients needing up to 4.5 years of monitoring with remote management capabilities and enhanced AI-powered accuracy in arrhythmia detection, including pediatric patients.
View LINQ II Insertable Cardiac Monitor →Choose QFR if…
Choose QFR if your primary need is to quantitatively assess the functional significance of coronary artery lesions directly from X-ray angiographic images. This software is best suited for cardiologists in the cath lab who require precise 3D reconstruction and AI-driven analysis to guide revascularization decisions without additional invasive procedures.
View QFR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | LINQ II Insertable Cardiac Monitor | QFR |
|---|---|---|
| Deployment | Subcutaneous implant with remote monitoring via mobile app or home communicator. | On-premise (integrates into cath lab environment) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
LINQ II Insertable Cardiac MonitorTool A offers a hybrid deployment with a mobile app for patients and a home communicator, alongside remote programming for clinicians, providing flexible and continuous monitoring. This broad patient-centric approach, coupled with clinician remote management, gives it an edge in overall usability across the care continuum.
Clinical Value
QFRWhile both tools offer significant clinical value, Tool B's ability to non-invasively derive Quantitative Flow Ratio (QFR) from standard angiograms using AI is a transformative innovation. This provides functional significance of coronary lesions, guiding revascularization decisions without the need for invasive pressure wires or adenosine.
Pricing & Value
QFRBoth tools lack public pricing transparency, making a direct comparison of 'value for money' challenging. However, Tool B explicitly highlights its cost-effectiveness by eliminating the need for expensive pressure wires and adenosine, which are typically required for traditional FFR procedures.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorTool A, backed by Medtronic, a global medical device leader with a long history, vast customer base (over 1 million patients), and explicit HIPAA compliance, demonstrates superior enterprise readiness. Tool B, while FDA cleared, is from a smaller, more specialized company with less publicly documented enterprise-level support and an 'unknown' HIPAA compliance status in the provided facts.
Innovation
QFRBoth tools are innovative, but Tool B's application of AI and deep learning to derive functional significance (QFR) from standard angiograms is a more disruptive innovation. This capability potentially changes the standard of care for lesion assessment by reducing the need for invasive FFR procedures.
Support & Docs
LINQ II Insertable Cardiac MonitorTool A, as a Medtronic product, benefits from the company's extensive global infrastructure, offering comprehensive support and documentation for both patients and healthcare professionals. This includes dedicated patient service specialists, detailed manuals, and online resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | LINQ II Insertable Cardiac Monitor | QFR |
|---|---|---|
| Name | LINQ II Insertable Cardiac Monitor | QFR |
| Company | Medtronic | Medis Medical Imaging |
| Description | The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. | QFR by QFR Solutions bv is an FDA-cleared AI-powered medical software for the visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments, aiding cardiologists in lesion assessment. |
| Key Features | AccuRhythm™ AI algorithms for enhanced accuracy, Remote programming capability, Up to 4.5 years of continuous monitoring, MRI compatibility (1.5 and 3.0T), MyCareLink Heart™ mobile app for data transmission, MyCareLink Relay™ home communicator option, Innovative PVC detection algorithm, Pediatric indication (ages 2+) | Visualization of X-ray angiographic images, Analysis and calculations in coronary vessel segments, Automatic detection and editing of vessel contours, 3D reconstruction of coronary vessel models, Accurate anatomical quantification of lesions, Quantitative Flow Ratio (QFR) assessment for functional significance, AI-enabled end-diastolic frame selection, Deep learning for precise alignment of angiographic projections |
| Data Export | PDF reports can be generated and saved within Electronic Health Records via the Reveal LINQ™ Mobile Manager app. | Yes, graphical reports can be exported to PACS, and numerical results via .XML or .JSON for research. DICOM SR output is also available. |
| Customer Count | More than 1 million patients worldwide have received a Medtronic ICM. | 3600+ licenses sold worldwide. |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and QFR.